Minya Lu

493 total citations
17 papers, 159 citations indexed

About

Minya Lu is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Minya Lu has authored 17 papers receiving a total of 159 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Minya Lu's work include Antifungal resistance and susceptibility (5 papers), Fungal Infections and Studies (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Minya Lu is often cited by papers focused on Antifungal resistance and susceptibility (5 papers), Fungal Infections and Studies (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Minya Lu collaborates with scholars based in China, United States and Hong Kong. Minya Lu's co-authors include Xin Hou, Yingchun Xu, Xiaomei Zhang, Yingchun Xu, Te Liang, Hongye Wang, Yongzhe Li, Meng Xiao, Dan Wang and Jiayu Dai and has published in prestigious journals such as Frontiers in Microbiology, Molecular & Cellular Proteomics and BMJ Open.

In The Last Decade

Minya Lu

14 papers receiving 158 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minya Lu China 8 109 68 24 22 14 17 159
Esma Eren Türkiye 7 50 0.5× 45 0.7× 12 0.5× 16 0.7× 15 1.1× 39 120
Antje Häder Germany 7 78 0.7× 68 1.0× 13 0.5× 48 2.2× 9 0.6× 12 161
Reham Khedr Egypt 6 82 0.8× 67 1.0× 10 0.4× 8 0.4× 15 1.1× 25 122
Christoph Zurl Austria 7 179 1.6× 118 1.7× 8 0.3× 20 0.9× 5 0.4× 12 208
Minh-Vu H Nguyen United States 10 185 1.7× 150 2.2× 22 0.9× 15 0.7× 21 1.5× 23 253
Cato Jacobs Belgium 7 106 1.0× 72 1.1× 28 1.2× 13 0.6× 4 0.3× 8 146
С. Н. Хостелиди Russia 6 178 1.6× 135 2.0× 17 0.7× 6 0.3× 6 0.4× 22 202
Ali Alhadab United States 6 112 1.0× 114 1.7× 16 0.7× 24 1.1× 29 2.1× 11 195
Albert Dunbar Netherlands 7 145 1.3× 145 2.1× 20 0.8× 8 0.4× 21 1.5× 9 193
Lindsey te Brake Netherlands 7 209 1.9× 132 1.9× 10 0.4× 31 1.4× 19 1.4× 19 352

Countries citing papers authored by Minya Lu

Since Specialization
Citations

This map shows the geographic impact of Minya Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minya Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minya Lu more than expected).

Fields of papers citing papers by Minya Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minya Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minya Lu. The network helps show where Minya Lu may publish in the future.

Co-authorship network of co-authors of Minya Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Minya Lu. A scholar is included among the top collaborators of Minya Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minya Lu. Minya Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sun, Hongli, Qiuyue Chen, Hu Long, et al.. (2025). Integrative study of pulmonary microbiome and clinical diagnosis in pulmonary tuberculosis patients. Microbiology Spectrum. 13(8). e0156324–e0156324.
2.
Su, Huiting, Dong Zhang, Minya Lu, et al.. (2025). The role of mNGS in the diagnosis of talaromycosis and case series. BMC Infectious Diseases. 25(1). 191–191. 2 indexed citations
3.
Zhou, Menglan, Wenjing Chen, Dong Zhang, et al.. (2025). Identification and characterization of a novel human adenovirus type HAdV-D116. Frontiers in Microbiology. 16. 1566316–1566316. 1 indexed citations
4.
Luo, Zhengyu, Li Zhang, Zhengyin Liu, et al.. (2025). The efficacy and safety of eravacycline in the treatment of patients with pneumonia in respiratory departments: A real-world multicenter retrospective study. Journal of Global Antimicrobial Resistance. 45. 196–201.
5.
Chen, Xinfei, Minya Lu, Yao Wang, et al.. (2024). Emergence and clonal expansion of Aeromonas hydrophila ST1172 that simultaneously produces MOX-13 and OXA-724. Antimicrobial Resistance and Infection Control. 13(1). 28–28. 1 indexed citations
6.
Zhang, Li, Menglan Zhou, Ziran Wang, et al.. (2024). Comparison of Clinical Characteristics and Treatment Outcome Between Localized and Disseminated Nocardiosis in a Tertiary Hospital in China. Infection and Drug Resistance. Volume 17. 2379–2387.
7.
Lin, Jing, Li Zhang, Menglan Zhou, et al.. (2023). Combination Therapy of Ceftazidime/Avibactam for the Treatment of Patients Infected with Carbapenem-Resistant Klebsiella pneumoniae: A Multicenter Retrospective Study. Infectious Diseases and Therapy. 12(8). 2165–2177. 5 indexed citations
8.
Xiao, Meng, David S. Perlin, Yanan Zhao, et al.. (2022). Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China. Emerging Microbes & Infections. 12(1). 37 indexed citations
9.
Lin, Jing, Menglan Zhou, Jialong Chen, et al.. (2022). De-escalation from Echinocandins to Azole Treatment in Critically Ill Patients with Candidemia. International Journal of Infectious Diseases. 121. 69–74. 2 indexed citations
10.
Qin, Xuzhen, Erhei Dai, Haolong Li, et al.. (2021). The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19. BMC Immunology. 22(1). 14–14. 9 indexed citations
11.
Dong, Fen, Ke Huang, Xiaoxia Ren, et al.. (2021). Factors associated with inpatient length of stay among hospitalised patients with chronic obstructive pulmonary disease, China, 2016–2017: a retrospective study. BMJ Open. 11(2). e040560–e040560. 11 indexed citations
12.
Zhang, Jingjia, Dong Zhang, Juan Du, et al.. (2021). Rapid diagnosis of Talaromyces marneffei infection assisted by metagenomic next-generation sequencing in a HIV-negative patient. IDCases. 23. e01055–e01055. 9 indexed citations
13.
Hou, Xin, et al.. (2020). Application of the Technology of Serum Specific Antibody in Detecting 2019 Novel Coronavirus. 11(6). 649–653. 3 indexed citations
14.
Lu, Minya, Li Zhang, Yue Li, et al.. (2020). Recommendation for the diagnosis and management of immune checkpoint inhibitor related infections. Thoracic Cancer. 11(3). 805–809. 7 indexed citations
15.
Zhang, Li, Shu-Ying Yu, Sharon C.-A. Chen, et al.. (2020). Molecular Characterization of Candida parapsilosis by Microsatellite Typing and Emergence of Clonal Antifungal Drug Resistant Strains in a Multicenter Surveillance in China. Frontiers in Microbiology. 11. 1320–1320. 19 indexed citations
16.
Hou, Xin, Xiaomei Zhang, Xian Wu, et al.. (2020). Serum Protein Profiling Reveals a Landscape of Inflammation and Immune Signaling in Early-stage COVID-19 Infection. Molecular & Cellular Proteomics. 19(11). 1749–1759. 42 indexed citations
17.
Niu, Hongtao, Wenquan Niu, Tao Yu, et al.. (2019). Association of RAGE gene multiple variants with the risk for COPD and asthma in northern Han Chinese. Aging. 11(10). 3220–3237. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026